Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-02

Clinical Trial Update: Developing Hyperpolarized 129Xe MRI Biomarkers for Evaluation of Pulmonary Arterial Hypertension

View source ↗

Summary

Clinical trial investigating hyperpolarized 129Xe MRI biomarkers to evaluate pulmonary arterial hypertension; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Kansas Medical Center | Conditions: Pulmonary Arterial Hypertension | Status: ACTIVE_NOT_RECRUITING